BridgeBio Pharma BBIO
NASDAQ BBIO
$67.25 +0.34 (+0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Cash & Current Investments (2018 - 2026)

Updated

BridgeBio Pharma (BBIO) posted Cash & Current Investments of $720.16 million for Q2 2026, down 4.9% from $756.89 million a year earlier and down 23.4% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Pharma's Cash & Current Investments came in at $587.48 million, down 13.7% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
  • In prior years, BridgeBio Pharma's Cash & Current Investments was $681.1 million in FY2024 (+56.6%), $434.88 million in FY2023 (+1.5%), $428.27 million in FY2022 (-45.6%) and $787.52 million in FY2021 (+29.7%).
  • Quarterly Cash & Current Investments has run from a low of $266.32 million in Q3 2024 to a high of $940.19 million in Q1 2026 over five years.
  • On a year-over-year basis, Cash & Current Investments increased in five of the last eight quarters, with growth averaging 34.6%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2025, with growth of 142.5%; the weakest was Q3 2024, with a decline of 51.0%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $940.19 million (Q1 2026), $587.48 million (Q4 2025) and $645.94 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 BridgeBio Pharma 13.13 Bn 10.25 Bn 228.63 Mn 720.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 720.16 Mn
Mar 31, 2026 940.19 Mn
Dec 31, 2025 587.48 Mn
Sep 30, 2025 645.94 Mn
Jun 30, 2025 756.89 Mn
Mar 31, 2025 540.60 Mn
Dec 31, 2024 681.10 Mn
Sep 30, 2024 266.32 Mn
Jun 30, 2024 447.77 Mn
Mar 31, 2024 519.69 Mn
Dec 31, 2023 434.88 Mn
Sep 30, 2023 543.27 Mn
Jun 30, 2023 352.93 Mn
Mar 31, 2023 457.17 Mn
Dec 31, 2022 428.27 Mn
Sep 30, 2022 558.32 Mn
Jun 30, 2022 688.56 Mn
Mar 31, 2022 633.45 Mn
Dec 31, 2021 787.52 Mn
Sep 30, 2021 599.61 Mn
API Access

BridgeBio Pharma Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BBIO&period=max&api_key=YOUR_API_KEY